Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Umeclidinium Bromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 185,189Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Anoro Ellipta

    02 8Incruse Ellipta

    03 8Trelegy Ellipta

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 305

    2019 Revenue in Millions : 363

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 758

    2019 Revenue in Millions : 713

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 1,135

    2019 Revenue in Millions : 718

    Growth (%) : 58

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 682

    2020 Revenue in Millions : 749

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 277

    2020 Revenue in Millions : 301

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 1,647

    2020 Revenue in Millions : 1,122

    Growth (%) : 49

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Incruse Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Incruse Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GSK

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 242

    2021 Revenue in Millions : 277

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Anoro Ellipta

    Umeclidinium, Vilanterol

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Anoro Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GSK

    Umeclidinium, Vilanterol

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 595

    2021 Revenue in Millions : 682

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GSK

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 2,132

    2021 Revenue in Millions : 1,647

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Trelegy Ellipta

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Trelegy Ellipta

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GSK

    Fluticasone Furoate, Vilanterol Trifenatate, Umeclidinium Bromide

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2023 Revenue in Millions : 2,377

    2022 Revenue in Millions : 2,132

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF